3-51986395-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000666.3(ACY1):​c.437-20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0387 in 1,607,980 control chromosomes in the GnomAD database, including 4,791 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 2159 hom., cov: 32)
Exomes 𝑓: 0.032 ( 2632 hom. )

Consequence

ACY1
NM_000666.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.33

Publications

9 publications found
Variant links:
Genes affected
ACY1 (HGNC:177): (aminoacylase 1) This gene encodes a cytosolic, homodimeric, zinc-binding enzyme that catalyzes the hydrolysis of acylated L-amino acids to L-amino acids and an acyl group, and has been postulated to function in the catabolism and salvage of acylated amino acids. This gene is located on chromosome 3p21.1, a region reduced to homozygosity in small-cell lung cancer (SCLC), and its expression has been reported to be reduced or undetectable in SCLC cell lines and tumors. The amino acid sequence of human aminoacylase-1 is highly homologous to the porcine counterpart, and this enzyme is the first member of a new family of zinc-binding enzymes. Mutations in this gene cause aminoacylase-1 deficiency, a metabolic disorder characterized by central nervous system defects and increased urinary excretion of N-acetylated amino acids. Alternative splicing of this gene results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream ABHD14A (abhydrolase domain containing 14A) gene, as represented in GeneID:100526760. A related pseudogene has been identified on chromosome 18. [provided by RefSeq, Nov 2010]
ABHD14A-ACY1 (HGNC:38856): (ABHD14A-ACY1 readthrough) This locus represents naturally occurring read-through transcription between the neighboring abhydrolase domain containing 14A (ABHD14A) and aminoacylase 1 (ACY1) genes on chromosome 3. The read-through transcript encodes a protein that shares sequence identity with the downstream gene product but its N-terminal region is distinct due to the use of an alternate start codon relative to the upstream gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 3-51986395-C-T is Benign according to our data. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-51986395-C-T is described in CliVar as Benign. Clinvar id is 256754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.309 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACY1NM_000666.3 linkc.437-20C>T intron_variant Intron 6 of 14 ENST00000636358.2 NP_000657.1 Q03154-1V9HWA0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACY1ENST00000636358.2 linkc.437-20C>T intron_variant Intron 6 of 14 1 NM_000666.3 ENSP00000490149.1 Q03154-1
ABHD14A-ACY1ENST00000463937.1 linkc.740-20C>T intron_variant Intron 7 of 15 5 ENSP00000420487.1 C9JMV9

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16259
AN:
151878
Hom.:
2135
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.313
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.0524
Gnomad ASJ
AF:
0.0231
Gnomad EAS
AF:
0.0703
Gnomad SAS
AF:
0.0675
Gnomad FIN
AF:
0.0164
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0207
Gnomad OTH
AF:
0.0920
GnomAD2 exomes
AF:
0.0513
AC:
12145
AN:
236718
AF XY:
0.0472
show subpopulations
Gnomad AFR exome
AF:
0.320
Gnomad AMR exome
AF:
0.0272
Gnomad ASJ exome
AF:
0.0277
Gnomad EAS exome
AF:
0.0768
Gnomad FIN exome
AF:
0.0198
Gnomad NFE exome
AF:
0.0217
Gnomad OTH exome
AF:
0.0427
GnomAD4 exome
AF:
0.0315
AC:
45875
AN:
1455984
Hom.:
2632
Cov.:
33
AF XY:
0.0315
AC XY:
22773
AN XY:
723778
show subpopulations
African (AFR)
AF:
0.325
AC:
10842
AN:
33342
American (AMR)
AF:
0.0313
AC:
1369
AN:
43772
Ashkenazi Jewish (ASJ)
AF:
0.0270
AC:
701
AN:
25968
East Asian (EAS)
AF:
0.0742
AC:
2935
AN:
39562
South Asian (SAS)
AF:
0.0627
AC:
5357
AN:
85426
European-Finnish (FIN)
AF:
0.0188
AC:
995
AN:
52984
Middle Eastern (MID)
AF:
0.0837
AC:
474
AN:
5660
European-Non Finnish (NFE)
AF:
0.0182
AC:
20172
AN:
1109106
Other (OTH)
AF:
0.0504
AC:
3030
AN:
60164
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2570
5140
7711
10281
12851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
948
1896
2844
3792
4740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16331
AN:
151996
Hom.:
2159
Cov.:
32
AF XY:
0.105
AC XY:
7812
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.314
AC:
12945
AN:
41288
American (AMR)
AF:
0.0523
AC:
800
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0231
AC:
80
AN:
3470
East Asian (EAS)
AF:
0.0699
AC:
361
AN:
5166
South Asian (SAS)
AF:
0.0673
AC:
325
AN:
4826
European-Finnish (FIN)
AF:
0.0164
AC:
174
AN:
10624
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0207
AC:
1408
AN:
68014
Other (OTH)
AF:
0.0934
AC:
197
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
603
1206
1809
2412
3015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0438
Hom.:
800
Bravo
AF:
0.122
Asia WGS
AF:
0.110
AC:
384
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 27, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.023
DANN
Benign
0.52
PhyloP100
-2.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs323893; hg19: chr3-52020411; COSMIC: COSV68344565; COSMIC: COSV68344565; API